Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics

View through CrossRef
AbstractO-GalNAc glycans (or mucin O-glycans) play pivotal roles in diverse biological and pathological processes, including tumor growth and progression. Structurally defined O-GalNAc glycans are essential for functional studies but synthetic challenges and their inherent structural diversity and complexity have limited access to these compounds. Herein, we report an efficient and robust chemoenzymatic modular assembly (CEMA) strategy to construct structurally diverse O-GalNAc glycans. The key to this strategy is the convergent assembly of O-GalNAc cores 1–4 and 6 from three chemical building blocks, followed by enzymatic diversification of the cores by 13 well-tailored enzyme modules. A total of 83 O-GalNAc glycans presenting various natural glycan epitopes are obtained and used to generate a unique synthetic mucin O-glycan microarray. Binding specificities of glycan-binding proteins (GBPs) including plant lectins and selected anti-glycan antibodies towards these O-GalNAc glycans are revealed by this microarray, promoting their applicability in functional O-glycomics. Serum samples from colorectal cancer patients and healthy controls are assayed using the array reveal higher bindings towards less common cores 3, 4, and 6 than abundant cores 1 and 2, providing insights into O-GalNAc glycan structure-activity relationships.
Title: Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics
Description:
AbstractO-GalNAc glycans (or mucin O-glycans) play pivotal roles in diverse biological and pathological processes, including tumor growth and progression.
Structurally defined O-GalNAc glycans are essential for functional studies but synthetic challenges and their inherent structural diversity and complexity have limited access to these compounds.
Herein, we report an efficient and robust chemoenzymatic modular assembly (CEMA) strategy to construct structurally diverse O-GalNAc glycans.
The key to this strategy is the convergent assembly of O-GalNAc cores 1–4 and 6 from three chemical building blocks, followed by enzymatic diversification of the cores by 13 well-tailored enzyme modules.
A total of 83 O-GalNAc glycans presenting various natural glycan epitopes are obtained and used to generate a unique synthetic mucin O-glycan microarray.
Binding specificities of glycan-binding proteins (GBPs) including plant lectins and selected anti-glycan antibodies towards these O-GalNAc glycans are revealed by this microarray, promoting their applicability in functional O-glycomics.
Serum samples from colorectal cancer patients and healthy controls are assayed using the array reveal higher bindings towards less common cores 3, 4, and 6 than abundant cores 1 and 2, providing insights into O-GalNAc glycan structure-activity relationships.

Related Results

Pathogenic potential of galactose‐deficient IgA1 in IgA nephropathy
Pathogenic potential of galactose‐deficient IgA1 in IgA nephropathy
SUMMARY: Recent studies have demonstrated that immune complexes (IC) in the circulation and mesangial deposits in IgA nephropathy (IgAN) patients contain IgA1 molecules ...
Abstract 1450: Tumor-associated glycans interact with macrophages through class-A scavenger receptor
Abstract 1450: Tumor-associated glycans interact with macrophages through class-A scavenger receptor
Abstract Introduction. Tumor initiation and growth are associated with modifications to the glycan structure of glycoproteins, glycolipids and proteoglycans present ...
Sulfated N-glycans Upregulation in Sera Predicts Early-Stage Breast Cancer in Patients
Sulfated N-glycans Upregulation in Sera Predicts Early-Stage Breast Cancer in Patients
Abstract Alterations in sulfated glycans are associated with several pathological conditions, including cancer. However, analysis of sulfated glycans poses challeng...
Glycoremodeling of monoclonal antibodies
Glycoremodeling of monoclonal antibodies
Monoclonal antibodies (mAbs) are therapeutic glycoproteins mostly used in the areas of oncology and immunology. The structure of an mAb can be divided into the Fab fragment and the...
Sulfated N-glycan Upregulation in Sera Predicts Early-Stage Breast Cancer
Sulfated N-glycan Upregulation in Sera Predicts Early-Stage Breast Cancer
Abstract Background Breast cancer (BC) is a significant global health concern among women, and early detection plays a pivotal role in enhancing patient survival rates. Al...
The First Total Synthesis of Ganglioside GalNAc‐GD1a, a Target Molecule for Autoantibodies in Guillain–Barré Syndrome
The First Total Synthesis of Ganglioside GalNAc‐GD1a, a Target Molecule for Autoantibodies in Guillain–Barré Syndrome
AbstractThe first synthesis of ganglioside GalNAc‐GD1a, featuring efficient glycan assembly and a cyclic glucosyl ceramide as a versatile unit for ganglioside synthesis is describe...

Back to Top